We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$156M
1-Year Est. Return
14.89%
This Fund
S&P 500
This Quarter
Est. Return
-0.68%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$604M
AUM Growth
-$213M
(-26%)
Cap. Flow
-$186M
Cap. Flow
% of AUM
-30.79%
Top 10 Holdings %
Top 10 Hldgs %
13.62%
Holding
1,036
New
389
Increased
70
Reduced
105
Closed
470
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$12.4M |
| 2 |
Advanced Micro Devices
AMD
|
+$10.8M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.35M |
| 4 |
Workday
WDAY
|
+$7.63M |
| 5 |
Coca-Cola
KO
|
+$7.56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$15.4M |
| 2 |
Amgen
AMGN
|
+$11.2M |
| 3 |
Salesforce
CRM
|
+$9.62M |
| 4 |
Danaher
DHR
|
+$9.18M |
| 5 |
Union Pacific
UNP
|
+$8.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.33% |
| 2 | Consumer Discretionary | 16.35% |
| 3 | Healthcare | 12% |
| 4 | Industrials | 10.07% |
| 5 | Consumer Staples | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Sonos
SONO
$1.85B
| $288K | 0.05% |
+26,959
| New | +$354K |
|
402
NETSCOUT
NTCT
$2.79B
| $285K | 0.05% |
+13,549
| New | +$305K |
|
403
Westlake Corp
WLK
$8.95B
| $284K | 0.05% |
+2,841
| New | +$315K |
|
404
Prestige Consumer Healthcare
PBH
$2.21B
| $284K | 0.05% |
+3,300
| New | +$271K |
|
405
Cabot Corp
CBT
$4.09B
| $283K | 0.05% |
+3,400
| New | +$293K |
|
406
Under Armour Class C
UA
$2.07B
| $283K | 0.05% |
+47,500
| New | +$324K |
|
407
NCR Voyix
VYX
$1.04B
| $278K | 0.05% |
28,560
-17,500
| -38% | -$205K |
|
408
Bio-Techne
TECH
$11.3B
| $276K | 0.05% |
4,715
-6,685
| -59% | -$453K |
|
409
TG Therapeutics
TGTX
$8.12B
| $276K | 0.05% |
+7,000
| New | +$236K |
|
410
Palo Alto Networks
PANW
$307B
| $273K | 0.05% |
+1,600
| New | +$296K |
|
411
LGI Homes
LGIH
$1.18B
| $273K | 0.05% |
4,100
-1,395
| -25% | -$113K |
|
412
Buckle
BKE
$2.04B
| $272K | 0.05% |
+7,109
| New | +$308K |
|
413
Weyerhaeuser
WY
$16.1B
| $272K | 0.05% |
9,300
-9,400
| -50% | -$280K |
|
414
Tecnoglass Holdings
TGLS
$1.6B
| $271K | 0.04% |
+3,787
| New | +$282K |
|
415
Steven Madden
SHOO
$2.96B
| $269K | 0.04% |
+10,100
| New | +$355K |
|
416
Flowers Foods
FLO
$1.3B
| $268K | 0.04% |
+14,115
| New | +$270K |
|
417
Tarsus Pharmaceuticals
TARS
$3.66B
| $268K | 0.04% |
5,214
+1,100
| +27% | +$54.4K |
|
418
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.68B
| $266K | 0.04% |
+9,100
| New | +$258K |
|
419
Teck Resources
TECK
$31.7B
| $266K | 0.04% |
7,300
-72,042
| -91% | -$2.99M |
|
420
Biogen
BIIB
$31.9B
| $265K | 0.04% |
+1,940
| New | +$277K |
|
421
Harley-Davidson
HOG
$2.87B
| $264K | 0.04% |
+10,465
| New | +$280K |
|
422
ABM Industries
ABM
$2.93B
| $264K | 0.04% |
+5,569
| New | +$286K |
|
423
Oxford Industries
OXM
$444M
| $263K | 0.04% |
4,481
-712
| -14% | -$51.2K |
|
424
Repligen
RGEN
$9.86B
| $263K | 0.04% |
2,066
-4,512
| -69% | -$695K |
|
425
Coty
COTY
$2.33B
| $263K | 0.04% |
+48,000
| New | +$301K |
|
Similar funds
MCM
MFG
AFW
ADBIC
HSM
FWM
PIA
CCP
Bayesian Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Bayesian Capital Management held 1,036 positions worth $604M, down 26% from $817M the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Bayesian Capital Management withdrew a net $186M in Q1 2025, closing 470 positions and reducing 105 holdings. Its most notable exit was Amgen, an estimated $11.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Bayesian Capital Management opened a new position in Advanced Micro Devices worth $9.96M.
- Bayesian Capital Management's largest Q1 2025 buy was Advanced Micro Devices: 96,900 shares worth $9.96M.
- Bayesian Capital Management added most to Cisco in Q1 2025, an estimated $12.4M increase.
- Bayesian Capital Management's biggest Q1 2025 reduction was Nike, cutting an estimated $15.4M.
- Bayesian Capital Management fully exited Amgen in Q1 2025, selling an estimated $11.2M.
- Bayesian Capital Management's ten largest holdings make up 14% of its $604M portfolio in Q1 2025.
- Bayesian Capital Management opened 389 new positions and closed 470 in Q1 2025.
- Bayesian Capital Management's portfolio value fell 26% quarter-over-quarter to $604M.
Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.